Unapproved does not necessarily mean unlawful, but it does mean they have not been assessed for safety, quality and effectiveness by the Therapeutic Goods Administration (TGA)
Whether those effects translate directly to women in the GLP-1-therapy-plus-weight-loss context requires additional research that hasn't been published yet
Unlike diet or dosage, this isnt entirely within someones control, though its important to expect some variability, treating any results from clinical studies as guidelines rather than certain outcomes
The FDA has warned patients to be cautious with unapproved GLP-1 products and notes that compounded drugs are not reviewed by the agency for safety, effectiveness, or quality before marketing
Later on, I found out, this was 2011 [00:14:00] University of Texas in Austin did a study on the liposome technology product of glirathione
doi: 10.1186/s12933-022-01575-9